| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |